{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T05:31:39Z","timestamp":1762061499574,"version":"build-2065373602"},"reference-count":6,"publisher":"American Psychiatric Association Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1999,7,1]]},"DOI":"10.1176\/ajp.156.7.1117a","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:19:12Z","timestamp":1659111552000},"page":"1117a-1118","source":"Crossref","is-referenced-by-count":22,"title":["Treating Visual Hallucinations With Donepezil"],"prefix":"10.1176","volume":"156","author":[{"given":"WILLIAM J.","family":"BURKE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WILLIAM H.","family":"ROCCAFORTE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEVEN P.","family":"WENGEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R1567BCFDJEDD","doi-asserted-by":"crossref","unstructured":"Berrios GE, Brook P: Visual hallucinations and sensory delusions in the elderly. Br J Psychiatry 1984; 144:662\u2013664","DOI":"10.1192\/bjp.144.6.662"},{"key":"R1567BCFBDIHE","doi-asserted-by":"crossref","unstructured":"Cummings JL, Gorman DG, Shapira J: Physostigmine ameliorates the delusions of Alzheimer\u2019s disease. Biol Psychiatry 1993; 33:536\u2013541","DOI":"10.1016\/0006-3223(93)90009-3"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Kaufer DI, Cummings JL, Christine D: Effect of tacrine on behavioral symptoms in Alzheimer\u2019s disease: an open-label study. J Geriatr Psychiatry Neurol 1996; 9:1\u20136","DOI":"10.1177\/089198879600900101"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B: Metrifonate treatment of the cognitive deficits of Alzheimer\u2019s disease: Metrifonate Study Group. Neurology 1998; 50:1214\u20131221","DOI":"10.1212\/WNL.50.5.1214"},{"key":"R1567BCFBAFJG","doi-asserted-by":"crossref","unstructured":"Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A, Shannon HE, Tollefson GD, Rasmussen D, Bymaster FP, Hurley DJ, Potter WZ, Paul SM: Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol 1997; 54:465\u2013473","DOI":"10.1001\/archneur.1997.00550160091022"},{"key":"R1567BCFDIHII","doi-asserted-by":"crossref","unstructured":"Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, Perry RH: Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 1990; 55:1454\u20131456","DOI":"10.1111\/j.1471-4159.1990.tb03162.x"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ajp.psychiatryonline.org\/doi\/10.1176\/ajp.156.7.1117a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T21:42:30Z","timestamp":1722375750000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.156.7.1117a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,1]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,7,1]]}},"alternative-id":["10.1176\/ajp.156.7.1117a"],"URL":"https:\/\/doi.org\/10.1176\/ajp.156.7.1117a","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"type":"print","value":"0002-953X"},{"type":"electronic","value":"1535-7228"}],"subject":[],"published":{"date-parts":[[1999,7,1]]}}}